Dare Bioscience, Inc. (DARE)

Balance Sheet (Annual)

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011 - 2012
Cash & Equivalents	51.67	4.67	4.78	6.81	7.56	0.04	75.91	51.17	5.49	16.71	Upgrade
Cash & Cash Equivalents	51.67	4.67	4.78	6.81	7.56	0.04	75.91	51.17	5.49	16.71	Upgrade
Cash Growth	1006.64%	-2.31%	-29.77%	-9.97%	16845.01%	-99.94%	48.33%	832.47%	-67.15%	-	Upgrade
Receivables	1.15	0.46	0.56	0.03	0.28	0	1.39	1.66	0.96	0.36	Upgrade
Other Current Assets	2.48	1.85	1.11	0.4	0.51	0	0	0	0	0	Upgrade
Total Current Assets	55.3	6.98	6.44	7.24	8.35	0.04	77.3	52.84	6.45	17.06	Upgrade
Property, Plant & Equipment	0.03	0.04	0.06	0.01	0	0	0.58	0.34	0.25	0.44	Upgrade
Goodwill and Intangibles	0	0	0	0	5.19	0	0	0	0	0	Upgrade
Other Long-Term Assets	0.49	0.53	0.94	0.58	0.72	-	0.35	0.22	0.14	0.16	Upgrade
Total Long-Term Assets	0.51	0.57	1	0.59	5.91	0	0.92	0.56	0.38	0.6	Upgrade
Total Assets	55.81	7.55	7.44	7.83	14.26	0.04	78.23	53.39	6.83	17.66	Upgrade
Accounts Payable	2.1	1.02	1.08	0.46	0.31	0.01	2.23	1.26	0.91	0.9	Upgrade
Deferred Revenue	1	1	0	0	0	0	0	0	0	0	Upgrade
Current Debt	0.27	0.71	0.41	0	0	0.7	7.65	3.12	11.96	2.87	Upgrade
Other Current Liabilities	12.68	4.92	4.12	0.63	0.66	0.05	6.46	3.68	2.27	2.76	Upgrade
Total Current Liabilities	16.05	7.66	5.61	1.09	0.97	0.76	16.34	8.06	15.15	6.52	Upgrade
Long-Term Debt	0	0.04	0.39	0.01	0	0	12.67	0	3.12	6.26	Upgrade
Other Long-Term Liabilities	1	1	1	0	0	-	0.47	0.01	82.86	84.92	Upgrade
Total Long-Term Liabilities	1	1.04	1.39	0.01	0	0	13.15	0.01	85.98	91.18	Upgrade
Total Liabilities	17.05	8.7	7	1.1	0.97	0.76	29.48	8.07	101.13	97.7	Upgrade
Total Debt	0.27	0.76	0.8	0.01	0	0.7	20.32	3.12	15.08	9.13	Upgrade
Debt Growth	-64.25%	-5.45%	8142.74%	-	-	-96.57%	550.58%	-79.29%	65.25%	-	Upgrade
Common Stock	149.04	70.37	44.57	35.79	25.54	0.02	210.12	167.11	4.14	1.26	Upgrade
Retained Earnings	-110.13	-71.43	-44.02	-28.97	-12.23	-0.73	-161.38	-121.78	-98.44	-81.3	Upgrade
Comprehensive Income	-0.15	-0.09	-0.1	-0.1	-0.02	0	0	0	0	0	Upgrade
Shareholders' Equity	38.75	-1.15	0.44	6.73	13.29	-0.71	48.74	45.33	-94.3	-80.04	Upgrade
Total Liabilities and Equity	55.81	7.55	7.44	7.83	14.26	0.04	78.23	53.39	6.83	17.66	Upgrade
Net Cash / Debt	51.4	3.91	3.98	6.8	7.56	-0.65	55.58	48.05	-9.59	7.58	Upgrade
Net Cash / Debt Growth	1213.79%	-1.68%	-41.44%	-10.10%	-	-	15.68%	-	-	-	Upgrade
Net Cash Per Share	0.84	0.13	0.26	0.63	2.34	-0.78	21.86	33.03	-140.20	124.40	Upgrade
Working Capital	39.24	-0.68	0.83	6.15	7.38	-0.71	60.97	44.78	-8.7	10.54	Upgrade
Book Value Per Share	0.63	-0.04	0.03	0.63	4.11	-0.85	19.17	31.15	-1.00	-1.00	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).